 |
> publications
> pharmacy practice program
> pharmaceutical sciences program
> faculty research interests
|
|
|
|
Department of Pharmacy Practice Faculty Publications
Within the Past 2 Years
Dr. Nicole Albanese |
Paolini NM, Coe H; Systemic lupus erythematosus ; 2008 Jan.
|
Dr. Edward Bednarczyk |
Constantinescu R, McDermott MP, Dicenzo R, de Blieck EA, Hyson HC, Beal MF, Bednarczyk EM, Bogdanov M, Metakis LJ, Browne SE, Lorenzo BJ, Ravina B, Kieburtz K; A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone). J Clin Pharmacol; 2007 Dec; 47(12). Journal Article
Kassab MY, Majid A, Bakhtar O, Farooq MU, Patel K, Bednarczyk EM; Transcranial Doppler measurements in migraine and nitroglycerin headache. J Headache Pain; 2007 Oct; 8(5). Journal Article
Constantinescu R, McDermott MP, Dicenzo R, de Blieck EA, Hyson HC, Beal MF, Bednarczyk EM, Bogdanov M, Metakis LJ, Browne SE, Lorenzo BJ, Ravina B, Kieburtz K; A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q10 (Ubiquinone). J Clin Pharmacol; 2007 Oct. Journal Article
Kassab MY, Majid A, Farooq MU, Azhary H, Hershey LA, Bednarczyk EM, Graybeal DF, Johnson MD; Transcranial Doppler: an introduction for primary care physicians. J Am Board Fam Med; 2007 Jan; 20(1). Journal Article
|
Dr. J. Edward Bell |
Krzyzanski W, Bell J; Modelling the geometric features and investigating electrical properties of dendrites in a fish thalamic neuron. Math Med Biol; 2007 Sep; 24(3). Journal Article
|
Mr. Terry Bellnier |
No Recent Publications
|
Dr. Angela Bosinski |
No Recent Publications
|
Dr. Peter Brody |
No Recent Publications
|
Dr. Linda Catanzaro |
Slish J, Ma Q, Zingman BS, Reichman RC, Fischl MA, Gripshover B, Forrest A, Brazeau D, Boston NS, Catanzaro L, DiFrancesco R, Morse GD; Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring. Ther Drug Monit; 2007 Oct; 29(5). Journal Article
|
Dr. Tammie Lee Demler |
No Recent Publications
|
Dr. Alan Forrest |
Yang JC, Tsuji BT, Forrest A; Optimizing use of quinolones in the critically ill. Semin Respir Crit Care Med; 2007 Dec; 28(6). Journal Article
Higgins N, Zingman BS, Slish J, Reichman RC, Fischl MA, Gripshover B, Tooley K, Boston N, Forrest A, Brazeau D, Catanzaro LM, Difrancesco R, Lliguicota F, Ma Q, Morse GD; Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir. Am J Addict; 2007 Nov; 16(6). Journal Article
Ma Q, Forrest A, Rosenkranz SL, Para MF, Yarasheski KE, Reichman RC, Morse GD; Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharm Drug Dispos; 2007 Nov; 29(2). Journal Article
Slish J, Ma Q, Zingman BS, Reichman RC, Fischl MA, Gripshover B, Forrest A, Brazeau D, Boston NS, Catanzaro L, DiFrancesco R, Morse GD; Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring. Ther Drug Monit; 2007 Oct; 29(5). Journal Article
Ma Q, Brazeau D, Forrest A, Morse GD; Advances in pharmacogenomics of antiretrovirals: an update. Pharmacogenomics; 2007 Sep; 8(9). Journal Article
Donovan JL, Schroeder WS, Tran MT, Foster K, Forrest A, Lee TB, Gandhi PJ; Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists. J Manag Care Pharm; 2007 Sep; 13(7). Clinical Trial
Moise PA, Sakoulas G, Forrest A, Schentag JJ; Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother; 2007 Jul; 51(7). In Vitro
Okusanya O, Forrest A, DiFrancesco R, Bilic S, Rosenkranz S, Para MF, Adams E, Yarasheski KE, Reichman RC, Morse GD; Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks. Antimicrob Agents Chemother; 2007 May; 51(5). Journal Article
Ma Q, Brazeau D, Zingman BS, Reichman RC, Fischl MA, Gripshover BM, Venuto CS, Slish JC, DiFrancesco R, Forrest A, Morse GD; Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV. Pharmacogenomics; 2007 Mar; 8(3). Journal Article
Smith PF, Tsuji B, Booker BM, Forrest A, Bajic S, Kelchlin P, Bhavnani SM, Jones RN, Ambrose PG, Tsuji BT; Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model. Diagn Microbiol Infect Dis; 2006 Dec; 56(4). Journal Article
Smith PF, Tsuji BT, Booker BM, Forrest A, Bajic S, Kelchin PA, Bhavani SM, Jones RN, Ambrose PJ; Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model Diagn Microbiol Infect Dis; 2006 Aug; 22. Journal Article
|
Dr. Francis Gengo |
Gengo FM, Rubin L, Robson M, Rainka M, Gengo MF, Mager DE, Bates V; Effects of Ibuprofen on the Magnitude and Duration of Aspirin's Inhibition of Platelet Aggregation: Clinical Consequences in Stroke Prophylaxis. J Clin Pharmacol; 2008 Jan; 48(1). Journal Article
|
Dr. Patty Havard |
No Recent Publications
|
Dr. Cynthia Lackie |
No Recent Publications
|
Dr. Qing Ma |
McCance-Katz EF, Moody DE, Morse GD, Ma Q, DiFrancesco R, Friedland G, Pade P, Rainey PM; Interaction between buprenorphine and atazanavir or atazanavir/ritonavir. Drug Alcohol Depend; 2007 Dec; 91(2-3). Journal Article
Ma Q, Forrest A, Rosenkranz SL, Para MF, Yarasheski KE, Reichman RC, Morse GD; Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharm Drug Dispos; 2007 Nov; 29(2). Journal Article
Higgins N, Zingman BS, Slish J, Reichman RC, Fischl MA, Gripshover B, Tooley K, Boston N, Forrest A, Brazeau D, Catanzaro LM, Difrancesco R, Lliguicota F, Ma Q, Morse GD; Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir. Am J Addict; 2007 Nov; 16(6). Journal Article
Slish J, Ma Q, Zingman BS, Reichman RC, Fischl MA, Gripshover B, Forrest A, Brazeau D, Boston NS, Catanzaro L, DiFrancesco R, Morse GD; Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring. Ther Drug Monit; 2007 Oct; 29(5). Journal Article
Ma Q, Brazeau D, Forrest A, Morse GD; Advances in pharmacogenomics of antiretrovirals: an update. Pharmacogenomics; 2007 Sep; 8(9). Journal Article
Maponga CC, Ma Q, Slish JC, Morse GD; HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Top HIV Med; 2007 Jun; 15(3). Journal Article
McCabe SM, Smith PF, Ma Q, Morse GD; Drug interactions between proton pump inhibitors and antiretroviral drugs. Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2). Journal Article
Ma Q, Brazeau D, Zingman BS, Reichman RC, Fischl MA, Gripshover BM, Venuto CS, Slish JC, DiFrancesco R, Forrest A, Morse GD; Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV. Pharmacogenomics; 2007 Mar; 8(3). Journal Article
Dobesh PP, Bosso J, Wortman S, Dager WE, Karpiuk EL, Ma Q, Zarowitz BJ, ACCP Task Force on Critical Pathways; Critical pathways: the role of pharmacy today and tomorrow Pharmacotherapy; 2006 Sep; 26(9). Journal Article
|
Dr. Charles Maponga |
Ball DE, Tagwireyi D, Maponga CC; Drug information in Zimbabwe: 1990-1999. Pharm World Sci; 2007 Jun; 29(3). Journal Article
Maponga CC, Ma Q, Slish JC, Morse GD; HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Top HIV Med; 2007 Jun; 15(3). Journal Article
|
Scott Monte |
No Recent Publications
|
Dr. Gene Morse |
McCance-Katz EF, Moody DE, Morse GD, Ma Q, DiFrancesco R, Friedland G, Pade P, Rainey PM; Interaction between buprenorphine and atazanavir or atazanavir/ritonavir. Drug Alcohol Depend; 2007 Dec; 91(2-3). Journal Article
Ma Q, Forrest A, Rosenkranz SL, Para MF, Yarasheski KE, Reichman RC, Morse GD; Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers. Biopharm Drug Dispos; 2007 Nov; 29(2). Journal Article
Higgins N, Zingman BS, Slish J, Reichman RC, Fischl MA, Gripshover B, Tooley K, Boston N, Forrest A, Brazeau D, Catanzaro LM, Difrancesco R, Lliguicota F, Ma Q, Morse GD; Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir. Am J Addict; 2007 Nov; 16(6). Journal Article
Slish J, Ma Q, Zingman BS, Reichman RC, Fischl MA, Gripshover B, Forrest A, Brazeau D, Boston NS, Catanzaro L, DiFrancesco R, Morse GD; Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring. Ther Drug Monit; 2007 Oct; 29(5). Journal Article
Ma Q, Brazeau D, Forrest A, Morse GD; Advances in pharmacogenomics of antiretrovirals: an update. Pharmacogenomics; 2007 Sep; 8(9). Journal Article
DiFrancesco R, DiCenzo R, Vicente G, Donnelly J, Martin TM, Colon LA, Schifito G, Morse GD; Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometry. J Pharm Biomed Anal; 2007 Sep; 44(5). Journal Article
Rosenkranz SL, Yarasheski KE, Para MF, Reichman RC, Morse GD; Antiretroviral drug levels and interactions affect lipid, lipoprotein and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic-pharmacodynamic analysis. Metab Syndr Relat Disord; 2007 Jun; 5(2). Journal Article
Maponga CC, Ma Q, Slish JC, Morse GD; HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Top HIV Med; 2007 Jun; 15(3). Journal Article
DiFrancesco R, Fischl MA, Donnelly J, Zingman BS, McCance-Katz EF, Moody DE, Reichman RC, Gripshover B, Morse GD; Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users. J Pharm Biomed Anal; 2007 May; 44(1). Journal Article
Okusanya O, Forrest A, DiFrancesco R, Bilic S, Rosenkranz S, Para MF, Adams E, Yarasheski KE, Reichman RC, Morse GD; Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks. Antimicrob Agents Chemother; 2007 May; 51(5). Journal Article
McCabe SM, Smith PF, Ma Q, Morse GD; Drug interactions between proton pump inhibitors and antiretroviral drugs. Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2). Journal Article
Ma Q, Brazeau D, Zingman BS, Reichman RC, Fischl MA, Gripshover BM, Venuto CS, Slish JC, DiFrancesco R, Forrest A, Morse GD; Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV. Pharmacogenomics; 2007 Mar; 8(3). Journal Article
Keil K, Hochreitter J, DiFrancesco R, Zingman BS, Reichman RC, Fischl MA, Gripshover B, Morse GD; Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application. Ther Drug Monit; 2007 Feb; 29(1). Journal Article
Cohen CJ, Colson AE, Sheble-Hall AG, McLaughlin KA, Morse GD; Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study. HIV Clin Trials; 2007 Jan; 8(1). Clinical Trial
McCance-Katz EF, Moody DE, Smith PF, Morse GD, Friedland G, Pade P, Baker J, Alvanzo A, Jatlow P, Rainey PM; Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir. Clin Infect Dis; 2006 Dec; 43 Su. Journal Article
McCance-Katz EF, Moody DE, Morse GD, Friedland G, Pade P, Baker J, Alvanzo A, Smith P, Ogundele A, Jatlow P, Rainey PM; Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine. Clin Infect Dis; 2006 Dec; 43 Su. Journal Article
Bruce RD, McCance-Katz E, Kharasch ED, Moody DE, Morse GD; Pharmacokinetic interactions between buprenorphine and antiretroviral medications. Clin Infect Dis; 2006 Dec; 43 Su. In Vitro
Motsinger AA, Ritchie MD, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D'Aquila RT, Johnson VA, Pollard RB, Merigan TC, Hirsch MS, Donahue JP, Kim RB, Haas DW; Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study. Pharmacogenet Genomics; 2006 Nov; 16(11). Journal Article
Keil, Kim, DiFrancesco R, Morse GD; Determination of tipranavir in human plasma by reverse phase liquid chromatography with UV detection using photodiode array Ther Drug Monit; 2006 Aug; 28(4). Journal Article
|
Dr. Joseph Paladino |
Iannini PB, Paladino JA, Lavin B, Singer ME, Schentag JJ; A case series of macrolide treatment failures in community acquired pneumonia. J Chemother; 2007 Oct; 19(5). Journal Article
Schentag JJ, Klugman KP, Yu VL, Adelman MH, Wilton GJ, Chiou CC, Patel M, Lavin B, Paladino JA; Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study. Int J Antimicrob Agents; 2007 Sep; 30(3). Journal Article
Paladino JA, Sunderlin JL, Adelman MH, Singer ME, Schentag JJ; Observations on vancomycin use in U.S. hospitals. Am J Health Syst Pharm; 2007 Aug; 64(15). Journal Article
Paladino JA, Eubanks DA, Adelman MH, Schentag JJ; Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia. J Am Geriatr Soc; 2007 May; 55(5). Comparative Study
Paladino JA, Adelman MH, Schentag JJ, Iannini PB; Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US. Pharmacoeconomics; 2007 Jan; 25(8). Journal Article
|
Dr. Mary Pasko |
Mergenhagen KA, Pasko MT, Pasko M; Daptomycin use after vancomycin-induced neutropenia in a patient with left-sided endocarditis. Ann Pharmacother; 2007 Sep; 41(9). Case Reports
|
Dr. William Prescott |
Prescott WA, Kusmierski KA; Clinical importance of carbapenem hypersensitivity in patients with self-reported and documented penicillin allergy. Pharmacotherapy; 2007 Jan; 27(1). Journal Article
|
Mr. Alfred Reiman |
No Recent Publications
|
Dr. Erin Slazak |
No Recent Publications
|
Dr. Kathleen Tornatore |
Difrancesco R, Frerichs V, Donnelly J, Hagler C, Hochreiter J, Tornatore KM; Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1). Journal Article
Tornatore KM, Dole KB, Gillis KA, Wallace P, Wilding G, Leca N, Yassa S, Venuto RC; Pharmacokinetic Factors Associated with Pharmacodynamics of Activated T lymphocytes during Immunosuppressive Therapy Amer. J. Transplant; 2007 Jul.
Singh N, Nainani N, Venuto RC, Gundroo AA, Qazi YA, Wadhawan S, Hasan M, Khalil F, Blessios GA, Tornatore KM, Murray BM; Impact of Alemtuzumab induction on Transplantation; 2007 Jul.
Singh N, Parimoo N, Ummadi S, Qazi YA, Murray BM, Shanahan T, Tornatore KM, Blessios GA, Venuto RC; Preformed CREG antibodies predispose to humoral rejection in renal transplant recipients induced with Campath-1H Clin. Transplantation; 2007 Jul.
Gillis KA, Quazi Y, Karam JS, Belessions GA, Schloen M, Venuto RC, Tornatore KM; Serial Pharmacodynamic Responses to Abbreviated Induction with Anti - Thymocyte Globulin in Renal Transplant Recipients Kidney International; 2007 Jun.
|
Dr. Brian Tsuji |
Yang JC, Tsuji BT, Forrest A; Optimizing use of quinolones in the critically ill. Semin Respir Crit Care Med; 2007 Dec; 28(6). Journal Article
Narita M, Tsuji BT, Yu VL; Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy; 2007 Aug; 27(8). Case Reports
Rose WE, Rybak MJ, Tsuji BT, Kaatz GW, Sakoulas G; Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function. J Antimicrob Chemother; 2007 Jun; 59(6). Journal Article
Tsuji BT, Rybak MJ, Cheung CM, Amjad M, Kaatz GW; Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn Microbiol Infect Dis; 2007 May; 58(1). Comparative Study
LaPlante KL, Rybak MJ, Tsuji B, Lodise TP, Kaatz GW, Tsuji BT; Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin. Antimicrob Agents Chemother; 2007 Apr; 51(4). Journal Article
Tsuji BT, Rybak MJ, Lau KL, Sakoulas G; Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother; 2007 Mar; 51(3). Journal Article
Smith PF, Tsuji B, Booker BM, Forrest A, Bajic S, Kelchlin P, Bhavnani SM, Jones RN, Ambrose PG, Tsuji BT; Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model. Diagn Microbiol Infect Dis; 2006 Dec; 56(4). Journal Article
Smith PF, Tsuji BT, Booker BM, Forrest A, Bajic S, Kelchin PA, Bhavani SM, Jones RN, Ambrose PJ; Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model Diagn Microbiol Infect Dis; 2006 Aug; 22. Journal Article
|
Dr. Robert Wahler |
No Recent Publications
|
Dr. Mark Wrobel |
No Recent Publications
|
Dr. Gina Zurick |
No Recent Publications
|
|
|
Faces & Stories |
 |
|
|
|
|
We interviewed students, faculty, and alumni—here's what they had to say.
» Learn more
|
|
|
